Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$73.94 - $80.67 $13,826 - $15,085
187 New
187 $14,000
Q1 2023

Apr 19, 2023

SELL
$77.31 - $88.08 $96,250 - $109,659
-1,245 Reduced 39.69%
1,892 $156,000
Q4 2022

Jan 17, 2023

BUY
$62.32 - $89.47 $195,497 - $280,667
3,137 New
3,137 $0
Q1 2022

Apr 18, 2022

SELL
$57.92 - $72.58 $186,039 - $233,126
-3,212 Closed
0 $0
Q4 2021

Jan 31, 2022

BUY
$64.88 - $73.64 $208,394 - $236,531
3,212 New
3,212 $233,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Carmel Capital Partners, LLC Portfolio

Follow Carmel Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmel Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carmel Capital Partners, LLC with notifications on news.